Skip to main content
. 2023 Feb 23;12(5):1805. doi: 10.3390/jcm12051805

Table 1.

Demographics and clinical characteristics for study population.

Variables Total (n = 57) Case (n = 12) Control (n = 45) p
Gestational age, weeks a 24.6 (23.4, 25.4) 25.3 (24.4, 26.1) 24.6 (23.3, 25) 0.119 b
Birth weight, g a 620 (540, 730) 680 (620, 835) 610 (520, 730) 0.106 b
Male sex 33 (58%) 5 (42%) 28 (62%) 0.200 c
Apgar score a
At 1 min 4 (3, 5) 4 (2.5, 5.5) 4 (3, 5) 0.584 b
At 5 min 7 (6, 8) 7 (5, 8) 7 (6, 9) 0.301 b
Small for gestational age 13 (23%) 2 (17%) 11 (24%) 0.713 c
Chorioamnionitis 28 (49%) 5 (42%) 23 (51%) 0.561 c
Premature rupture of membrane 17 (30%) 3 (25%) 14 (31%) 1.000 c
Antenatal corticosteroid use 56 (98%) 11 (92%) 45 (100%) 0.211 c
High-grade intraventricular hemorrhage 21 (37%) 3 (25%) 18 (40%) 0.504 c
Neonatal sepsis 52 (91%) 8 (67%) 44 (98%) 0.006 c
Acute kidney injury 22 (39%) 4 (33%) 18 (40%) 0.841 c
NSAIDs use 12 (21%) 4 (33%) 8 (18%) 0.254 c
HFOV support 32 (56%) 5 (42%) 27 (60%) 0.418 c
Preoperative pletelet counts, ×109/L d 154.1 ± 130.0 235.3 ± 161.5 132.4 ± 112.7 0.057 b
Postnatal age at laparotomy, days a 21 (14, 36) 30 (22, 45.5) 20 (12, 31) 0.018 b

Unless otherwise indicated, data are the number of patients, with percentages in parentheses. HFOV, high-frequency oscillatory ventilation. a Data are the median and interquartile range. b The p values are from a Wilcoxon rank sum test. c The p values are from Fisher’s exact test or a Chi-Square test, as appropriate. d Data are the mean and standard deviation.